DRIVEN BY A COMMON PURPOSE
Exceptional people achieve extraordinary things
OUR COMMITMENT
CellmAbs is a biotech company focused on discovering and developing cutting-edge oncology products, aiming to deliver the most effective and safe therapeutic and diagnostic solutions to treat cancer patients. Our ultimate goal is to cure cancer, and we work passionately every day to achieve it.
Our team comprises renowned scientists and international experts in the field of glycoimmunology and oncology. We also maintain partnerships with national and international research centers and oncology clinical institutes.
ETHICS AND INTEGRITY
CellmAbs operates openly, transparently, and with the highest degree of ethics and integrity. It includes defining and implementing Standard Operating Procedures to assure the compliance with the best practices:
Ensuring that the company complies with all applicable laws and regulations worldwide;
Continuously reinforce global commitment through business practices and ethical behaviors at all levels of the company;
Aiming to stay in line with the changing demands of global business in a competitive, ethical and innovative way, always committed to the idea that good citizenship makes sense in every business.
OUR PEOPLE
An international and high-perfomance r&d team together with a group of top tier biotech executives and scientists working to change the paradigm in Oncology treatment
Board of Directors
-
Nuno Prego R., PhD st.
Co-Founder, Chairman and CEO
-
Paula Videira, PhD
Co-Founder and CTO
-
Ricardo Perdigão Henriques, PhD
Non-Executive Director
-
Patrícia Costa, PhD
Non-Executive Director
-
Eliot Forster, PhD
Advisor to the Board
Scientific Advisory Board
-
Lúcio Lara Santos, MD, PhD
-
Ravi Chari, PhD
-
Gonçalo Bernardes, PhD